Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.

Blumenthal JA, Sherwood A, Rogers SD, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, O'Connell C, Johnson JJ, Patidar SM, Waugh R, Hinderliter A.

Clin Trials. 2007;4(5):548-59.


Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.

Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, O'Hayer CV, Mabe S, Johnson J, Doraiswamy PM, Jiang W, Schocken DD, Hinderliter AL.

J Am Coll Cardiol. 2012 Sep 18;60(12):1053-63. doi: 10.1016/j.jacc.2012.04.040. Epub 2012 Aug 1.


Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.


Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.

Roest AM, Carney RM, Stein PK, Freedland KE, Meyer H, Steinmeyer BC, de Jonge P, Rubin EH.

J Clin Psychiatry. 2012 Jan;73(1):31-6. doi: 10.4088/JCP.10m06455. Epub 2011 Aug 9.


[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.


Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.

Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schütze M, Scheunemann W, Allgaier AK, Coyne J, Henkel V.

Int J Neuropsychopharmacol. 2010 Feb;13(1):31-44. doi: 10.1017/S1461145709000224. Epub 2009 Apr 3.


Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Mann DL.

J Psychosom Res. 2011 Jul;71(1):13-7. doi: 10.1016/j.jpsychores.2010.11.006. Epub 2011 Jan 15.


Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, Krishnan R; SADHART-CHF Investigators.

J Am Coll Cardiol. 2010 Aug 24;56(9):692-9. doi: 10.1016/j.jacc.2010.03.068.


Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.


Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.

Jiang W, O'Connor C, Silva SG, Kuchibhatla M, Cuffe MS, Callwood DD, Zakhary B, Henke E, Arias RM, Krishnan R; SADHART-CHF Investigators.

Am Heart J. 2008 Sep;156(3):437-44. doi: 10.1016/j.ahj.2008.05.003. Epub 2008 Jul 7.


Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.

Cowan MJ, Freedland KE, Burg MM, Saab PG, Youngblood ME, Cornell CE, Powell LH, Czajkowski SM; ENRICHD Investigators.

Psychother Psychosom. 2008;77(1):27-37. Epub 2007 Dec 14.


Effects of exercise training on older patients with major depression.

Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR.

Arch Intern Med. 1999 Oct 25;159(19):2349-56.


Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

Glassman AH, Bigger JT, Gaffney M, Van Zyl LT.

Arch Gen Psychiatry. 2007 Sep;64(9):1025-31.


Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.

Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Finkel MS, Krishnan KR, Gaffney M, Harrison W, Califf RM, O'Connor CM; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group.

Circulation. 2003 Aug 26;108(8):939-44. Epub 2003 Aug 11. Erratum in: Circulation. 2003 Dec 23;108(25):3165.


Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.


Preventing depression after stroke: Results from a randomized placebo-controlled trial.

Almeida OP, Waterreus A, Hankey GJ.

J Clin Psychiatry. 2006 Jul;67(7):1104-9.


New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression.

Blumenthal JA.

Cleve Clin J Med. 2011 Aug;78 Suppl 1:S35-43. doi: 10.3949/ccjm.78.s1.06. Review.


The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study.

Zöger S, Svedlund J, Holgers KM.

J Clin Psychopharmacol. 2006 Feb;26(1):32-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk